A sandwich chemiluminescent magnetic microparticle immunoassay for cryptococcal antigen detection

References

• WHO. fungal priority pathogens list to guide research, development and public health action. Geneva: World Health Organization; 2022. Licence: CC BY-NC-SA 3.0 IGO.
   Google Scholar
• Warnock DW. Name changes for fungi of medical importance, 2012 to 2015. J Clin Microbiol. 2016 28;55(1):53–59. doi: 10.1128/JCM.00829-16
   PubMed Web of Science ®Google Scholar
• Hagen F, Khayhan K, Theelen B, et al. Recognition of seven species in the Cryptococcus gattii/Cryptococcus neoformans species complex. Fungal Genet Biol. 2015;78:16–48. doi: 10.1016/j.fgb.2015.02.009
   PubMed Web of Science ®Google Scholar
• Brown GD, Denning DW, Gow NA, et al. Hidden killers: human fungal infections. Sci Transl Med. 2012;4(165):165rv13. doi: 10.1126/scitranslmed.3004404
   PubMed Web of Science ®Google Scholar
• Rajasingham R, Smith RM, Park BJ, et al. Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis. Lancet Infect Dis. 2017;17(8):873–881. doi: 10.1016/S1473-3099(17)30243-8
   PubMed Web of Science ®Google Scholar
• Gushiken AC, Saharia KK, Baddley JW. Cryptococcosis. Infect Dis Clin North Am. 2021;35(2):493–514. doi: 10.1016/j.idc.2021.03.012
   PubMed Web of Science ®Google Scholar
• Skolnik K, Huston S, Mody CH. Cryptococcal lung infections. Clin Chest Med. 2017;38(3):451–464. doi: 10.1016/j.ccm.2017.04.007
   PubMed Web of Science ®Google Scholar
• Kwizera R, Akampurira A, Williams D, et al. Acridine orange fluorescent microscopy is more sensitive than India ink light microscopy in the rapid detection of cryptococcosis among CrAg positive HIV patients. PLOS ONE. 2017;12(7):e0182108. doi: 10.1371/journal.pone.0182108
   PubMed Web of Science ®Google Scholar
• Zhou Y, Lin PC, Ye JR, et al. The performance of serum cryptococcal capsular polysaccharide antigen test, histopathology and culture of the lung tissue for diagnosis of pulmonary cryptococcosis in patients without HIV infection. Infect Drug Resist. 2018;11:2483–2490. doi: 10.2147/IDR.S178391
   PubMed Web of Science ®Google Scholar
• Rajasingham R, Wake RM, Beyene T, et al. Cryptococcal meningitis diagnostics and screening in the era of point-of-care laboratory testing. J Clin Microbiol. 2019;57(1):e01238–18. doi: 10.1128/JCM.01238-18
   PubMed Web of Science ®Google Scholar
• Miller JM, Binnicker MJ, Campbell S, et al. A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2018 update by the infectious diseases society of America and the American society for microbiology. Clin Infect Dis. 2018;67(6):e1–e94. doi: 10.1093/cid/ciy381
   PubMed Web of Science ®Google Scholar
• Theel ES. Back to basics: when to order (and when not to order) serologic testing for the diagnosis of infectious diseases. Clin Chem. 2021;68(1):36–39. doi: 10.1093/clinchem/hvab166
   PubMed Web of Science ®Google Scholar
• Mariano Andrade R, Monteiro Almeida G, Alexandre DosReis G, et al. Glucuronoxylomannan of Cryptococcus neoformans exacerbates in vitro yeast cell growth by interleukin 10-dependent inhibition of CD4+ T lymphocyte responses. Cell Immunol. 2003;222(2):116–125. doi: 10.1016/s0008-8749(03)00116-3
   PubMed Web of Science ®Google Scholar
• Bhattacharjee AK, Bennett JE, Glaudemans CP. Capsular polysaccharides of Cryptococcus neoformans. Rev Infect Dis. 1984;6(5):619–624. doi: 10.1093/clinids/6.5.619
   PubMedGoogle Scholar
• Fisher KM, Montrief T, Ramzy M, et al. Cryptococcal meningitis: a review for emergency clinicians. Intern Emerg Med. 2021;16(4):1031–1042. doi: 10.1007/s11739-020-02619-2
   PubMed Web of Science ®Google Scholar
• Donnelly JP, Chen SC, Kauffman CA, et al. Revision and update of the consensus definitions of invasive fungal disease from the European organization for research and treatment of cancer and the mycoses study group education and research consortium. Clin Infect Dis. 2020;71(6):1367–1376. doi: 10.1093/cid/ciz1008
   PubMed Web of Science ®Google Scholar
• Kwizera R, Omali D, Tadeo K, et al. Evaluation of the dynamiker cryptococcal antigen lateral flow assay for the diagnosis of hiv-associated cryptococcosis. J Clin Microbiol. 2021;59(3):e02421–20. doi: 10.1128/JCM.02421-20
   PubMed Web of Science ®Google Scholar
• Noguera MC, Escandón P, Rodríguez J, et al. Comparison of two commercial tests (Immy vs. Dynamiker) for cryptococcal capsular antigen. Rev Soc Bras Med Trop. 2021;54:e03072021. doi: 10.1590/0037-8682-0307-2021
   Web of Science ®Google Scholar
• Song S, Choi S, Ryu S, et al. Highly sensitive paper-based immunoassay using photothermal laser speckle imaging. Biosens Bioelectron. 2018;117:385–391. doi: 10.1016/j.bios.2018.06.024
   PubMed Web of Science ®Google Scholar
• Dubbels M, Granger D, Theel ES, et al. Low Cryptococcus antigen titers as determined by lateral flow assay should Be interpreted cautiously in patients without prior diagnosis of cryptococcal infection. J Clin Microbiol. 2017;55(8):2472–2479. doi: 10.1128/JCM.00751-17
   PubMed Web of Science ®Google Scholar
• Boulware DR, Rolfes MA, Rajasingham R, et al. Multisite validation of cryptococcal antigen lateral flow assay and quantification by laser thermal contrast. Emerg Infect Dis. 2014;20(1):45–53. doi: 10.3201/eid2001.130906
   PubMed Web of Science ®Google Scholar
• Hansen J, Slechta ES, Gates-Hollingsworth MA, et al. Large-scale evaluation of the immuno-mycologics lateral flow and enzyme-linked immunoassays for detection of cryptococcal antigen in serum and cerebrospinal fluid. Clin Vaccine Immunol. 2013;20(1):52–55. doi: 10.1128/CVI.00536-12
   PubMed Web of Science ®Google Scholar
• Jiang H, Liu C, Qu Q, et al. Development of SERS-based immunoassay for the detection of cryptococcosis biomarker. Anal Bioanal Chem. 2022;414(16):4645–4654. doi: 10.1007/s00216-022-04081-9
   PubMed Web of Science ®Google Scholar
• Luo Z, Zhang L, Zeng R, et al. Near-infrared light-excited core-core-shell ucnp@au@cds upconversion nanospheres for ultrasensitive photoelectrochemical enzyme immunoassay. Anal Chem. 2018;90(15):9568–9575. doi: 10.1021/acs.analchem.8b02421
   PubMed Web of Science ®Google Scholar
• Chen S, Yu Z, Wang Y, et al. Block-polymer-restricted sub-nanometer Pt nanoclusters nanozyme-enhanced immunoassay for monitoring of cardiac troponin I. Anal Chem. 2023;95(38):14494–14501. doi: 10.1021/acs.analchem.3c03249
   PubMed Web of Science ®Google Scholar
• Shi Z, Cao L, Luo J, et al. A chemiluminescent magnetic microparticle immunoassay for the detection of antibody against African swine fever virus. Appl Microbiol Biotechnol. 2023;107(11):3779–3788. doi: 10.1007/s00253-023-12518-z
   PubMed Web of Science ®Google Scholar
• Kyme H, Lee CT, Kim YT, et al. Self-enzyme chemiluminescence immunoassay capable of rapidly diagnosing the infection of influenza a (H1N1) virus. Talanta. 2019;192:189–196. doi: 10.1016/j.talanta.2018.09.049
   PubMed Web of Science ®Google Scholar
• Gao Y, Zeng Y, Liu X, et al. Liposome-mediated in situ formation of type-I heterojunction for amplified photoelectrochemical immunoassay. Anal Chem. 2022;94(11):4859–4865. doi: 10.1021/acs.analchem.2c00283
   PubMed Web of Science ®Google Scholar
• Huang L, Cai G, Zeng R, et al. Contactless photoelectrochemical biosensor based on the ultraviolet-assisted gas sensing interface of three-dimensional sns2 nanosheets: from mechanism reveal to practical application. Anal Chem. 2022;94(26):9487–9495. doi: 10.1021/acs.analchem.2c02010
   PubMedGoogle Scholar
• Guidelines for The Diagnosis. Prevention and management of cryptococcal disease in HIV‑infected adults, adolescents and children: supplement to the 2016 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Geneva: World Health Organization; 2018.
   Google Scholar
• Beyene T, Zewde AG, Balcha A, et al. Inadequacy of high-dose fluconazole monotherapy among cerebrospinal fluid cryptococcal antigen (crag)-positive human immunodeficiency virus-infected persons in an ethiopian crag screening program. Clin Infect Dis. 2017;65(12):2126–2129. doi: 10.1093/cid/cix613
   PubMed Web of Science ®Google Scholar
• Wake RM, Britz E, Sriruttan C, et al. High cryptococcal antigen titers in blood are predictive of subclinical cryptococcal meningitis among human immunodeficiency virus-infected patients. Clin Infect Dis. 2018;66(5):686–692. doi: 10.1093/cid/cix872
   PubMed Web of Science ®Google Scholar
• Ahmadi M, Ghoorchian A, Dashtian K, et al. Application of magnetic nanomaterials in electroanalytical methods: a review. Talanta. 2021;225:121974. doi: 10.1016/j.talanta.2020.121974
   PubMed Web of Science ®Google Scholar
• Stueber DD, Villanova J, Aponte I, et al. Magnetic nanoparticles in biology and medicine: past, present, and future trends. Pharmaceutics. 2021;13(7):943. doi: 10.3390/pharmaceutics13070943
   PubMed Web of Science ®Google Scholar
• Cinquanta L, Fontana DE, Bizzaro N. Chemiluminescent immunoassay technology: what does it change in autoantibody detection? Auto Immun Highlights. 2017;8(1):9. doi: 10.1007/s13317-017-0097-2
   PubMed Web of Science ®Google Scholar
• Sánchez-Cano A, Ruiz-Vega G, Vicente-Gómez S, et al. Development of a fast chemiluminescent magneto-immunoassay for sensitive Plasmodium falciparum detection in whole blood. Anal Chem. 2021;93(37):12793–12800. doi: 10.1021/acs.analchem.1c03242
   PubMed Web of Science ®Google Scholar
• Ben Ismail M, de la Serna E, Ruiz-Vega G, et al. Using magnetic beads and signal amplifiers to produce short and simple immunoassays :application to MMP-9 detection in plasma samples. Anal Chim Acta. 2018;999:144–154. doi: 10.1016/j.aca.2017.11.013
   Web of Science ®Google Scholar